Der er ingen relevant klinisk forskel i insulin detemir farmakokinetiske egenskaber mellem ældre og yngre patienter eller mellem patienter med nedsat nyre - eller leverfunktion og raske personer.
There was no clinically relevant difference in pharmacokinetics of insulin detemir between elderly and young subjects or between subjects with renal or hepatic impairment and healthy subjects.